APELLIS PHARMACEUTICALS INC's ticker is and the CUSIP is 03753UAB2. A total of 21 filers reported holding APELLIS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,379 | -54.9% | 12,242,000 | -14.0% | 0.02% | -50.0% |
| Q2 2023 | $34,113 | +4.7% | 14,242,000 | -18.3% | 0.04% | -2.3% |
| Q1 2023 | $32,583 | +3.5% | 17,442,000 | -14.4% | 0.04% | 0.0% |
| Q4 2022 | $31,471 | -99.9% | 20,378,000 | +40.5% | 0.04% | +4.9% |
| Q3 2022 | $28,333,000 | +150.0% | 14,500,000 | +91.6% | 0.04% | +173.3% |
| Q2 2022 | $11,331,000 | -28.7% | 7,566,000 | -24.3% | 0.02% | -16.7% |
| Q1 2022 | $15,891,000 | -30.7% | 10,000,000 | -33.9% | 0.02% | -25.0% |
| Q4 2021 | $22,945,000 | -11.5% | 15,127,000 | +8.0% | 0.02% | -17.2% |
| Q2 2021 | $25,917,000 | -32.1% | 14,000,000 | -38.1% | 0.03% | -39.6% |
| Q4 2020 | $38,169,000 | +65.3% | 22,616,000 | +5.2% | 0.05% | +50.0% |
| Q3 2020 | $23,085,000 | – | 21,500,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DeepCurrents Investment Group LLC | 39,528,000 | $49,938,921 | 2.17% |
| LINDEN ADVISORS LP | 15,000,000 | $18,816,676 | 0.19% |
| Verition Fund Management LLC | 12,454 | $15,645,338 | 0.18% |
| WOLVERINE ASSET MANAGEMENT LLC | 11,766,000 | $14,863,606 | 0.17% |
| PALISADE CAPITAL MANAGEMENT, LP | 1,017,000 | $1,284,573 | 0.04% |
| LAZARD ASSET MANAGEMENT LLC | 12,242,000 | $15,379 | 0.02% |
| KORNITZER CAPITAL MANAGEMENT INC /KS | 300,000 | $371,070 | 0.01% |
| D. E. Shaw & Co., Inc. | 5,000,000 | $6,267,238 | 0.01% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| CITIGROUP INC | 504,000 | $623,398 | 0.00% |